Spruce Biosciences Company Insiders
| SPRB Stock | USD 0.33 0.02 5.71% |
Spruce Biosciences employs about 22 people. The company is managed by 8 executives with a total tenure of roughly 52 years, averaging almost 6.0 years of service per executive, having 2.75 employees per reported executive. Analysis of Spruce Biosciences' management performance can provide insight into the company performance.
Spruce |
Spruce Biosciences Management Team Effectiveness
The company has return on total asset (ROA) of (0.3035) % which means that it has lost $0.3035 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5755) %, meaning that it created substantial loss on money invested by shareholders. Spruce Biosciences' management efficiency ratios could be used to measure how well Spruce Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.Spruce Biosciences Workforce Comparison
Spruce Biosciences is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 642. Spruce Biosciences holds roughly 22.0 in number of employees claiming about 3% of equities under Health Care industry.
Spruce Biosciences Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Spruce Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Spruce Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Spruce Biosciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Spruce Biosciences Notable Stakeholders
A Spruce Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Spruce Biosciences often face trade-offs trying to please all of them. Spruce Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Spruce Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Michael Grey | Executive Chairman | Profile | |
| Kirk MD | Interim Director | Profile | |
| CPA CPA | Pres CFO | Profile | |
| MD III | Chief Officer | Profile | |
| Libbie MBA | Chief Officer | Profile | |
| P Ramtin | Senior Operations | Profile | |
| Heidi MPH | Senior Quality | Profile | |
| MPH MD | CEO Director | Profile |
About Spruce Biosciences Management Performance
The success or failure of an entity such as Spruce Biosciences often depends on how effective the management is. Spruce Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Spruce management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Spruce management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in Daly City, California. Spruce Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people.
Please note, the presentation of Spruce Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Spruce Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Spruce Biosciences' management manipulating its earnings.
Spruce Biosciences Workforce Analysis
Traditionally, organizations such as Spruce Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Spruce Biosciences within its industry.Spruce Biosciences Manpower Efficiency
Return on Spruce Biosciences Manpower
| Revenue Per Employee | 458.6K | |
| Revenue Per Executive | 1.3M | |
| Net Loss Per Employee | 2.2M | |
| Net Loss Per Executive | 6M | |
| Working Capital Per Employee | 3.5M | |
| Working Capital Per Executive | 9.7M |
Complementary Tools for Spruce Stock analysis
When running Spruce Biosciences' price analysis, check to measure Spruce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spruce Biosciences is operating at the current time. Most of Spruce Biosciences' value examination focuses on studying past and present price action to predict the probability of Spruce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spruce Biosciences' price. Additionally, you may evaluate how the addition of Spruce Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |